Plasma vitamin C for predicting cardiovascular disease: More than a nutritional biomarker

Acta Clinica Belgica

Volumn 64, Issue 4, 2009, Pages 341-343

  Langlois, M R ^a   De Buyzere, M L ^a   Delanghe, J R ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Genetic polymorphisms; Inflammation; Iron overload; Nutrition; Vitamin C

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; HAPTOGLOBIN;

CARDIOVASCULAR DISEASE; DIETARY INTAKE; DISEASE MARKER; LIFESTYLE; NOTE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 70350170734     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.053     Document Type: Note

References (24)

1. Kris-Etherson PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL for the Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004;110:637-641
2. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland. BMJ 1997;314:634-638 (Pubitemid 27099877)
3. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:1811-1818 (Pubitemid 41716488)
4. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw K-T. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20649 participants of the European Prospective Investigation into Cancer-Norfolk prospective population study. Amy Clin Nutr 2008;87:64-69
5. Padayatty SJ, Levine M. Fruit and vegetables: think variety, go ahead, eat! (editorial) Am J Clin Nutr 2008;87:5-7.
6. Hampl JS, Taylor CA, Johnston CS. Vitamin C Deficiency and Depletion in the United States: The Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 2004;94:870-875
7. Delanghe JR, Langlois MR, De Buyzere ML, Torek M. Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism. Clin Chem 2007;53:1397-1400
8. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001;103:1863-1881 (Pubitemid 32328399)
9. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002;105:2632-2637 (Pubitemid 34596040)
10. Everett BM, Kurth T, Buring JE, Ridker PM.The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Card 2006;48:2235-2242 (Pubitemid 44855447)
11. Devriese AS, Borrey D, Mahieu E, et al. Oral vitamin C administration increases lipid oxidation in hemodialysis patients. Nephron Clin Pract 2008;108:28-34. (Pubitemid 351253442)
12. Lee D-H, Folsom AR, Harnack L, Halliwell B, Jacobs Jr DR. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 2004;80:1194-1200
13. Livrea MA, Tesoriere L, Pintaudi AM et al. Oxidative stress and antioxidant status in β-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996;88:3608-14. (Pubitemid 26365599)
14. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 1997;66:606-610
15. Na N, Delanghe JR, Taes YE, Torck M, Baeyens WR, Ouyang J. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta 2006;365:319-324 (Pubitemid 43196454)
16. Van Vlierberghe H, Langlois M, Delanghe J. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta 2004;345:35-42. (Pubitemid 38749169)
17. Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, Tamargo RJ. Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 2007;38:3266-71. (Pubitemid 350175747)
18. Sadrzadeh SM, Saffari Y, Bozorgmehr J. Haptoglobin phenotypes in epilepsy. Clin Chem 2004;50:1095-1097
19. Saccucci P, Verdecchia M, Piciullo A et al. Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism. Neurogenetics 2004;5:245-248
20. Sadrzadeh SMH, Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 1988;82:1510-1515
21. Levy AP, Levy JE, Kalet-Litman S et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2007;27:134-140 (Pubitemid 46360390)
22. Milman U, Blum S, Shapira C et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype.A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol 2008;28:341-347 (Pubitemid 351161209)
23. Willcox BJ, Curb DJ, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiological studies. Am J Cardiol 2008;101(Suppl) :75D-86D.
24. Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr 2007;137:2171-2184 (Pubitemid 47529573)